The underlying pathophysiology driving chronic mucocutaneous candidiasis (CMC) in STAT1 gain-of-function (GOF) has been correlated to enhanced Th1 activity and decreased Th17 function. The gene discussed is STAT1; the disease is Chronic mucocutaneous candidosis.